30
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Angiogenesis in brain tumours.

      Nature reviews. Neuroscience

      Animals, Antineoplastic Agents, pharmacology, Blood Vessels, drug effects, pathology, physiopathology, Brain Edema, prevention & control, Brain Neoplasms, blood supply, drug therapy, Glioblastoma, Humans, Neovascularization, Pathologic, metabolism, Vascular Endothelial Growth Factor A, antagonists & inhibitors

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Despite aggressive surgery, radiotherapy and chemotherapy, malignant gliomas remain uniformly fatal. To progress, these tumours stimulate the formation of new blood vessels through processes driven primarily by vascular endothelial growth factor (VEGF). However, the resulting vessels are structurally and functionally abnormal, and contribute to a hostile microenvironment (low oxygen tension and high interstitial fluid pressure) that selects for a more malignant phenotype with increased morbidity and mortality. Emerging preclinical and clinical data indicate that anti-VEGF therapies are potentially effective in glioblastoma--the most frequent primary brain tumour--and can transiently normalize tumour vessels. This creates a window of opportunity for optimally combining chemotherapeutics and radiation.

          Related collections

          Author and article information

          Journal
          17643088
          10.1038/nrn2175

          Comments

          Comment on this article